CCR5 plays important roles in hepatitis b infection

Viral Immunology

Volumn 27, Issue 1, 2014, Pages 2-6

  Sanchooli, Javad ^a   Sanadgol, Nima ^b,c   Kazemi Arababadi, Mohammad ^d   Kennedy, Derek ^e  

^a ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ZABOL   (Iran)

^d RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

GENETIC POLYMORPHISM; HEPATITIS B; HUMAN; IMMUNOCOMPETENT CELL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW;

HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84893608715     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0067     Document Type: Review

References (49)

1. Abousaidi H, Vazirinejad R, Arababadi MK, et al. Lack of association between chemokine receptor 5 (CCR5) delta32 mutation and pathogenesis of asthma in Iranian patients. South Med J 2011;104:422-425
2. Ahmadabadi BN, Hassanshahi G, Khoramdelazad H, et al. Downregulation of CCR5 expression on the peripheral blood CD8( + ) T cells of Southeastern Iranian patients with chronic hepatitis B infection. Inflammation 2012;36:136-140
3. Ahn SH, Kim do Y, Chang HY, et al. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006;78: 1564-1571 (Pubitemid 44672498)
4. Al-Abdulhadi SA, Al-Rabia MW. Linkage and haplotype analysis for chemokine receptors clustered on chromosome 3p21.3 and transmitted in family pedigrees with asthma and atopy. Ann Saudi Med 2010;30:115-122
5. Arababadi MK, Ahmadabadi BN, Kennedy D. Current information on the immunological status of occult hepatitis B infection. Transfusion 2012;52:1819-1826
6. Arababadi MK, Hassanshahi G, Pourfathollah AA, et al. Post-transfusion occult hepatitis B (OBI): A global challenge for blood recipients and health authorities. Hepat Mon 2011;11:714-718
7. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G. Decreased expression of CCR5 on the NK cells in occult HBV infected patients. Lab Med 2010;41:735-738
8. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Peripheral blood CD8+ T cells CCR5 expression and its D 32 mutation in Iranian patients with occult hepatitis B infection. Lab Med 2010;41:226-230
9. Assar S, Arababadi MK, Ahmadabadi BN, et al. Occult hepatitis B virus (HBV) infection: A global challenge for medicine. Clin Lab 2012;58:1225-1230
10. Blanpain C, Libert F, Vassart G, Parmentier M. CCR5 and HIV infection. Rec Channels 2002;8:19-31
11. Carr DJ, Ash J, Lane TR, Kuziel WA. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol 2006;87:489-499
12. Chang HY, Ahn SH, Kim DY, et al. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection]. Korean J Hepatol 2005;11:116-124
13. Cheong JY, Cho SW, Choi JY, et al. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: Results from a large scale single ethnic population. J Korean Med Sci 2007;22:529-535
14. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010;58:258-266
15. Coenen M, Nattermann J. The role of CCR5 in HCV infection. Eur J Med Res 2010;15:97
16. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, et al. Expression of chemokines and their receptors in human and simian astrocytes: Evidence for a central role of TNFa and IFNc in CXCR4 and CCR5 modulation. Glia 2003;41:354-370 (Pubitemid 36314149)
17. Dawson TC, Beck MA, Kuziel WA, et al. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000;156: 1951-1959 (Pubitemid 30641764)
18. Ganczak M, Bohatyrewicz A, Szych Z, Bialecki P. Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital]. Chir Narzadow Ruchu Ortop Pol 2008;73:83-88
19. Gilliam BL, Riedel DJ, Redfield RR. Clinical use of CCR5 inhibitors in HIV and beyond. J Transl Med 2011;9:S9
20. Guerini FR, Delbue S, Zanzottera M, et al. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Biomed Pharmacother 2008;62:26-30
21. Jae YC, Sung WC, Jeong YC, et al. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: Results from a large scale single ethnic population. J Korean Med Sci. 2007;22:529-535
22. Jiang X, Zhang M, Lai Q, et al. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS One. 2011;6:e28871
23. Keynan Y, Juno J, Meyers A, et al. Chemokine receptor 5 D32 allele in patients with severe pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:1621
24. Khorramdelazad H, Hakimizadeh E, Hassanshahi G, et al. CCR5 D 32 mutation is not prevalent in Iranians with chronic HBV infection. J Med Virol 2013;85:964-968
25. Kroll-Palhares K, Silverio JC, Silva AA, et al. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8 + T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: Beneficial effects of TNF-A blockade. Memo rias Instit Oswaldo Cruz 2008;103:375-385 (Pubitemid 352026444)
26. Kuipers HF, Biesta PJ, Montagne LJ, et al. CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. Blood 2008;112: 1610-1619
27. Lai Y. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: Current progress and future prospects. Curr Stem Cell Res Ther 2012;7:310-317
28. Lee CK, Suh JH, Cho YS, et al. [Chemokine receptor expression of hepatitis B virus-specific CD8 + lymphocyte in chronic B viral infection]. Taehan Kan Hakhoe Chi 2002;8:363-370
29. Li H, Xie HY, Zhou L, et al. Polymorphisms of CCL3L1/ CCR5 genes and recurrence of hepatitis B in liver transplant recipients. Hepatobil Pancreat Dis Int 2011;10:593-598
30. Liu HG, Wang FS, Hong WG, et al. Genotyping and distribution of mutant CCR5D32, CCR2-641 and SDF1-3 A alleles in HIV-1 carriers and patients with sexually-transmitted diseases and chronic HBV infection. World Chin J Digest 2002;10:19-23
31. Miyara M, Wing K, Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3 + regulatory Tcell activation and expansion. J Allergy Clin Immunol 2009; 123:749-755; quiz 756-747
32. Moreno C, Gustot T, Nicaise C, et al. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 2005;42:854-862 (Pubitemid 41401123)
33. Mukai T, Iwasaki M, Gao P, et al. IL-12 plays a pivotal role in LFA-1-mediated T cell adhesiveness by up-regulation of CCR5 expression. J Leukocyte Biol 2001;70:422-430 (Pubitemid 32826130)
34. Schultz-Thater E, Frey DM, Margelli D, et al. Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR: a versatile monitoring and discovery tool. J Transl Med 2008;6:58
35. Shan KR, Wang CJ, Tan K, et al. Association of CCR5-59029 and IL10-819 polymorphisms with HBV infection in two Yi minority populations in Guizhou Province, China. World Chin J Digest 2010;18:3372-3377
36. Sheppard HW, Celum C, Michael NL, et al. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: Acquisition of syncytium-inducing virus at seroconversion. JAIDS 2002;29:307-313 (Pubitemid 34208541)
37. Shimada N, Yamamoto K, Kuroda MJ, et al. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol 2003;23:223-232 (Pubitemid 36521216)
38. Song JK, Park MH, Choi DY, et al. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and upregulation of IL-1Ra in melanoma model. PLoS One 2012;7:e33747
39. Sorce S, Myburgh R, Krause KH. The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol 2011; 93:297-311
40. Stoddart CA, Keir ME, McCune JM. IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo. PLoS Pathog 2010;6:e1000766
41. Suneetha PV, Sarin SK, Goyal A, et al. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006;44:856-863
42. Tan K, Shan KR, He Y, et al. Association of CCR5-D32 polymorphism with HBV infection in special population of Guizhou Province. World Chin J Digest 2009;17:2317-2319
43. Thio CL, Astemborski J, Bashirova A, et al. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol 2007;81:441-445 (Pubitemid 46067870)
44. Thio CL, Astemborski J, Thomas R, et al. Interaction between RANTES promoter variant and CCR5 Delta32 favors recovery from hepatitis B. J Immunol 2008;181:7944-7947
45. TrehanPati N, Geffers R, Sukriti, et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 2009;49:781-790
46. Vomaske J, Denton M, Kreklywich C, et al. Cytomegalovirus CC chemokine promotes immune cell migration. J Virol 2012;86:11833-11844
47. Wong JL, Berk E, Edwards RP, Kalinski P. IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8 + T cells to the tumor microenvironment. Cancer Res 2013;73:4653-4662
48. Wong M, Uddin S, Majchrzak B, et al. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J Biol Chem 2001;276:11427-11431 (Pubitemid 38089337)
49. Zhang K, Xu QH, Chen LB, et al. [Correlation of serum chemokine RANTES level with serum biochemical indices, HBeAg and HBV DNA load in patients with chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009;23:188-190